Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats

Metabolism: Clinical and Experimental

Volumn 49, Issue 5, 2000, Pages 588-593

  Nakayama, Kaori ^a,b,c,d,e   Hara, Tsutomu ^a,b,c,d,e   Kusunoki, Masataka ^a,b,c,d,e   Tsutsumi, Kazuhiko ^a,b,c,d,e   Minami, Asako ^a,b,c,d,e   Okada, Kazuko ^a,b,c,d,e   Sakamoto, Sadaichi ^a,b,c,d,e   Ohnaka, Masaharu ^a,b,c,d,e   Miyata, Tetsuro ^a,b,c,d,e   Nakamura, Takao ^a,b,c,d,e   Aoki, Takanari ^a,b,c,d,e   Fukatsu, Atsushi ^a,b,c,d,e   Nakaya, Yutaka ^a,b,c,d,e   Kakumu, Shinichi ^a,b,c,d,e  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(4 BROMO 2 CYANOPHENYL)CARBAMOYL]BENZYLPHOSPHONIC ACID DIETHYL ESTER; ALBUMIN; CREATININE; DOXORUBICIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIPOPROTEIN LIPASE ACTIVATOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HISTOPATHOLOGY; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; NEPHROSIS; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034071576     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)80032-3     Document Type: Article

References (53)

1. Brahm M Brammer M Balslov JT Prognosis in glomerulonephritis. III. A longitudinal analysis of changes in serum creatinine and proteinuria during the course of disease: Effect of immunosuppressive treatment Report from Copenhagen Study Group of Renal Disease J Intern Med 231 1992 339 347
2. Bogenschutz O Bohle A Batz C IgA nephritis: On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients Am J Nephrol 10 1990 137 147
3. D'Amico G Influence of clinical and histological features with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis Survey of the recent literature Am J Kidney Dis 20 1992 315 323
4. Donadio JV Bergstlah EJ Offord KP Clinical and histopathologic association with impaired renal function in IgA nephropathy Clin Nephrol 41 1994 65 71
5. Ibels LS Gyory AZ IgA nephropathy: Analysis of the natural history. Important factors in the progression of renal disease, and a review of the literature Medicine (Baltimore) 73 1994 79 102
6. Alamartine E Sabatier JC Guerin C Prognostic factors in mesangial IgA nephritis: An extensive study with univariate and multivariate analysis Am J Kidney Dis 18 1991 12 19
7. Diamond JR Effect of lipid abnormalities on the progression of renal damage. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis Kidney Int 39 suppl 31 1991 s29 s34
8. Moorhead JF Chan MK El-Nahas M Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease Lancet 2 1982 1309 1311
9. Kashyap ML Ooi BS Hynd RA Sequestration and excretion of high-density and low-density lipoproteins by the kidney in human nephrotic syndrome Artery 6 1979 108 121
10. Schainuck LI Striker GE Cutler RE Structural-functional correlations in renal disease. II. The correlations Hum Pathol 1 1970 631 641
11. Risdon RA Sloper JC De Wardener HE Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis Lancet 2 1968 363 366
12. Bohle A Mackensen-Haen S von Gise H Significance of tubulo-interstitial changes in the renal cortex for the excretory function and the concentration ability of the kidney: A morphometric contribution Am J Nephrol 7 1987 421 433
13. Bohle A Mackensen-Haen S von Gise H The consequences of tubulointerstitial changes for renal function in glomerulopathies Pathol Res Pract 186 1990 135 144
14. Tsutsumi K Inoue Y Shima A The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis J Clin Invest 92 1993 411 417
15. Tsutsumi K Inoue Y Shima A Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase—promoting agent, in STZ-induced diabetic rats Diabetes 44 1995 414 417
16. Tsutsumi K Inoue Y Hagi A The novel compound NO-1886 elevates plasma high-density lipoprotein cholesterol levels in hamsters and rabbits by increasing lipoprotein lipase without any effect on cholesteryl ester transfer protein activity Metabolism 46 1997 257 260
17. Chiba T Miura S Sawamura F Antiatherogenic effects of a novel lipoprotein lipase—enhancing agent in cholesterol-fed New Zealand white rabbits Atheroscler Thromb Vasc Biol 17 1997 2601 2608
18. Chan PC Robinson JD Yeung WC Lovastatin in glomerulonephritis patients with hyperlipidemia and heavy proteinuria Nephrol Dial Transplant 7 1992 93 99
19. Wanner C Bohler J Eckardt HG Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome Clin Nephrol 41 1994 138 143
20. Coleman JE Watson AR Hyperlipidemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood Pediatr Nephrol 10 1996 171 174
21. Vega GL Toto RD Grundy SM Metabolism of low density lipoproteins in nephrotic dyslipidemia Kidney Int 47 1995 579 586
22. Tsukamoto Y Kokubo T Horii A Effect of vegetarian soy diet on hyperlipidemia in nephrotic syndrome Nephron 73 1996 606 612
23. Teschner M Paczek L Schaefer L Lovastatin ameliorates depressed intraglomerular proteolytic activities in experimental nephrotic syndrome Res Exp Med (Berl) 194 1994 349 356
24. Al-Shurbaji A Skorve J Berge RK Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis Arterioscler Thromb 13 1993 1580 1586
25. Washio M Nanishi F Okuda S Alpha tocopherol improves focal glomerulonephritis in rats with Adriamycin-induced progressive renal failure Nephron 68 1994 347 352
26. Morimoto Y Hirano T Ebara T Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, suppresses very low-density lipoprotein secretion in puromycin aminonucleoside-nephrotic rats Nephron 67 1994 218 225
27. Kaysen GA Pan XM Couser WG Defective lipolysis persists in hearts of rats with Heymann nephritis in the absence of nephrotic plasma Am J Kidney Dis 22 1993 128 134
28. Liang K Vaziri ND Gene expression of lipoprotein lipase in experimental nephrosis J Lab Clin Med 130 1997 387 394
29. Kaysen GA Mehendru L Pan XM Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis Am J Physiol 263 1992 F335 F341
30. Kaysen GA Nephrotic hyperlipidemia: Primary abnormalities in both lipoprotein catabolism and synthesis Miner Electrolyte Metab 18 1992 212 216
31. Yoshino G Hirano T Nagata K Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglyceride: Overproduction of triglyceride-rich lipoprotein is not an obligatory factor J Lipid Res 34 1993 875 884
32. Liang K Vaziri ND Down regulation of hepatic lipase expression in experimental nephrotic syndrome Kidney Int 51 1997 1933 1937
33. Liang K Vaziri ND Acquired VLDL receptor deficiency in experimental nephrosis Kidney Int 51 1997 1761 1765
34. Al-Schurbaji A Berglund L Berge RK On the interrelationship between hepatic carnitine, fatty acid oxidation, and triglyceride biosynthesis in nephrosis Lipids 32 1997 847 852
35. Peric-Golla L Peric-Golla M Aortic and renal lesions in hypercholesterolemic adult, male, virgin Sprague-Dawley rats Atherosclerosis 46 1983 57 65
36. Kasiske BL O'Donnell MP Cleary MP Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats Kidney Int 35 1989 40 47
37. Kasiske BL O'Donnell MP Schmitz PG Renal injury of diet-induced hypercholesterolemia in rats Kidney Int 37 1990 880 891
38. Agarwal A Balla J Balla G Renal tubulae epithelial cells mimic endothelial cells upon exposure to oxidized LDL Am J Physiol 271 1996 F814 F823
39. Eddy AA Liu E McCulloch L Interstitial fibrosis in hypercholesterolemic rats: Role of oxidation, matrix synthesis, and proteolytic cascades Kidney Int 53 1998 1182 1189
40. Kees-Folts D Sadow JL Schreiner GF Tubular catabolism of albumin is associated with the release of an inflammatory lipid Kidney Int 45 1994 1697 1709
41. Thomas ME Schreiner GF Contribution of proteinuria to progressive renal injury: Consequences of tubular uptake of fatty acid bearing albumin 13 1993 385 398
42. Harris DC Tay C Nankivell BJ Lysosomal iron accumulation and tubular damage in rat puromycin nephrosis and aging Clin Exp Pharmacol Physiol 21 1994 73 81
43. Akfrey AC Toxicity of tubule fluid iron in the nephrotic syndrome Am J Physiol 263 1992 F637 F641
44. Morita Y Nomura A Yuzawa Y The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis J Am Soc Nephrol 8 1997 1363 1372
45. Nomura A Morita Y Maruyama S Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis Am J Pathol 151 1997 539 547
46. Thomas ME Morrison AR Schreiner GF Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line Am J Physiol 268 1995 F1117 F1184
47. Joles JA van Tol A Jansen EH Plasma lipoproteins and renal apolipoproteins in rats with chronic Adriamycin nephrosis Nephrol Dial Transplant 8 1993 831 838
48. Panduro A Castrillon L Pedraza-Chaverri J Regulation of apolipoprotein A-1 and E gene expression in liver and intestine of nephrotic and pair-fed rats Nephron 65 1993 100 107
49. Seishima M Noma A Compensatory increase in intestinal apolipoprotein A-IV mRNA levels in the experimental nephrotic rats Metabolism 42 1993 1375 1380
50. Kaysen GA Hoye E Jones H Jr Apolipoprotein A1 levels are increased in part as a consequence of reduced catabolism in nephrotic rats Am J Physiol 268 1995 F532 F540
51. Streather CP Owen JS Hendry BM Incubation of porcine high-density lipoprotein with the apical surface of LLC-PK1 renal tubular cells sustains the properties of oriented monolayers Nephrol Dial Transplant 11 1996 431 437
52. Ong AC Jowett TP Moorhead JF Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells Kidney Int 46 1994 1315 1321
53. Shafrir E Levy E Deckelbaum R Urinary excretion of apolipoproteins bound to HDL-like particle in rat nephrotic syndrome and their relation to plasma HDL Nephron 56 1990 24 29